Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen

FEBS Journal

Volumn 279, Issue 23, 2012, Pages 4283-4292

  Szabõ, András ^a   Sahin Tõth, Miklõs ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

chymotrypsin; elastase; pancreas; serine protease; trypsinogen

Indexed keywords

ALANINE; CALCIUM BINDING PROTEIN; CHYMOTRYPSIN; CHYMOTRYPSIN B1; CHYMOTRYPSIN B2; CHYMOTRYPSIN C; CHYMOTRYPSIN L1; ELASTASE; ELASTASE 2A; ELASTASE 3A; GLUTAMIC ACID; LEUCINE; PROTEINASE; TRYPSINOGEN; UNCLASSIFIED DRUG; CALCIUM; PANCREATIC ELASTASE;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; ENZYMOLOGY; METABOLISM; PANCREAS; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE;

CALCIUM; CHYMOTRYPSIN; HUMANS; PANCREAS; PANCREATIC ELASTASE; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SUBSTRATE SPECIFICITY; TRYPSINOGEN;

EID: 84870056923     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12018     Document Type: Article

References (22)

1. Chen JM, &, Férec C, (2000) Genes, cloned cDNAs, and proteins of human trypsinogens and pancreatitis-associated cationic trypsinogen mutations. Pancreas 21, 57-62.
2. Rinderknecht H, (1986) Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 31, 314-321.
3. Guy O, Lombardo D, Bartelt DC, Amic J, &, Figarella C, (1978) Two human trypsinogens. Purification, molecular properties, and N-terminal sequences. Biochemistry 17, 1669-1675.
4. Rinderknecht H, Renner IG, &, Carmack C, (1979) Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics and patients with pancreatitis and cancer of the pancreas. Gut 20, 886-891.
5. Rinderknecht H, Stace NH, &, Renner IG, (1985) Effects of chronic alcohol abuse on exocrine pancreatic secretion in man. Dig Dis Sci 30, 65-71.
6. Rinderknecht H, Renner IG, Abramson SB, &, Carmack C, (1984) Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 86, 681-692.
7. Yamashina I, (1956) The action of enterokinase on trypsinogen. Acta Chem Scand 10, 739-743.
8. Kukor Z, Tõth M, &, Sahin-Tõth M, (2003) Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Eur J Biochem 270, 2047-2058.
9. Rose SD, &, MacDonald RJ, (1997) Evolutionary silencing of the human elastase I gene (ELA1). Hum Mol Genet 6, 897-903.
10. Szepessy E, &, Sahin-Tõth M, (2006) Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans. Pancreatology 6, 117-122.
11. Witt H, Apte MV, Keim V, &, Wilson JS, (2007) Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology 132, 1557-1573.
12. Zhou J, &, Sahin-Tõth M, (2011) Chymotrypsin C (CTRC) mutations in chronic pancreatitis. J Gastroenterol Hepatol 26, 1238-1246.
13. Nemoda Z, &, Sahin-Tõth M, (2006) Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem 281, 11879-11886.
14. Szmola R, &, Sahin-Tõth M, (2007) Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci USA 104, 11227-11232.
15. Szabõ A, &, Sahin-Tõth M, (2012) Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C. J Biol Chem 287, 20701-20710.
16. Rosendahl J, Witt H, Szmola R, Bhatia E, O'zsvári B, Landt O, Schulz HU, Gress TM, Pfützer R, Löhr M, et al,. (2008) Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 40, 78-82.
17. Szabõ A, Héja D, Szakács D, Zboray K, Kékesi KA, Radisky ES, Sahin-Tõth M, &, Pál G, (2011) High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues. J Biol Chem 286, 22535-22545.
18. Szmola R, Bence M, Carpentieri A, Szabõ A, Costello CE, Samuelson J, &, Sahin-Tõth M, (2011) Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2. J Biol Chem 286, 1819-1827.
19. Sahin-Tõth M, (2000) Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem 275, 22750-22755.
20. Sahin-Tõth M, &, Tõth M, (2000) Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun 278, 286-289.
21. Bence M, &, Sahin-Tõth M, (2011) Asparagine-linked glycosylation of human chymotrypsin C is required for folding and secretion but not for enzyme activity. FEBS J 278, 4338-4350.
22. Schechter I, &, Berger A, (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27, 157-162.